CHRO Chromocell Therapeutics
- 0.696
- -0.074-9.62%
- 0.740
- +0.044+6.33%
Chromocell Therapeutics News
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | EFFECT: Others
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B4: Prospectus
Chromocell Therapeutics | 424B4: Prospectus
Chromocell Therapeutics | EFFECT: Others
Chromocell Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange
Chromocell Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Chromocell Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Chromocell Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Chromocell Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Chromocell Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Analysis
Price Target
No Data
No Data